![Nai De Si](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Nai De Si
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Nantong University
2
| College/University | Other Consumer Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Nai De Si via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Takara Bio USA, Inc.
![]() Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Hongwei Technologies Ltd.
![]() Hongwei Technologies Ltd. TextilesProcess Industries Hongwei Technologies Ltd. engages in the manufacture and sale of polyester differential fibers primarily to yarn and textile manufacturers located in the southern parts of China. It also provides customized services to its customers such as product testing, elasticity tuning and thickness fitting. The company was founded by Zhuang Xin Xin and Lin Ji Miao on March 3, 2005 and is headquartered in Xiamen, China. | Textiles | Director/Board Member | |
Nagoya University | College/University | Doctorate Degree | |
The Memorial Foundation, Inc. | Corporate Officer/Principal | ||
Biomics Biotechnologies Co., Ltd.
![]() Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Biotechnology | Chief Executive Officer | |
Zytogene, Inc. | Chief Tech/Sci/R&D Officer | ||
NT Omics, Inc. | Founder | ||
China Pharmaceutical University | College/University | Corporate Officer/Principal | |
BIOMICS BIOPHARMA LTD | Chemicals: Specialty | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 5 |
China | 3 |
Bermuda | 2 |
Verenigd Koninkrijk | 2 |
Japan | 2 |
Sectoraal
Health Technology | 3 |
Process Industries | 3 |
Consumer Services | 3 |
Health Services | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 2 |
Chairman | 2 |
Founder | 2 |
Sterkste connecties
Insiders | |
---|---|
Yuan Yuan Zhu | 10 |
Chao Dong Xing | 2 |